Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Melanoma × Radionuclide Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Odontogenic Cysts 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 12 Radiosurgery 7 Early Intervention, Educational 5 Surveys and Questionnaires 4 Standard of Care 4 Practice Guidelines as Topic 4 Methods 4 Educational Status 4 Surgical Procedures, Operative 3 Sentinel Lymph Node Biopsy 3 Nivolumab 3 Ipilimumab 3 Indocyanine Green 3 Immunotherapy 3 Cognitive Behavioral Therapy 3 Biopsy 3 pembrolizumab 2 montanide ISA 51 2 aldesleukin 2 X-Rays 2 Tomography, X-Ray Computed 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 In Situ Hybridization, Fluorescence 2 Immunohistochemistry 2 Immune Checkpoint Inhibitors 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Fluorescein 2 Diathermy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06666790 2024-10-31

DermaSensor Postmarket Surveillance Study

DermaSensor, Inc.

Phase NA Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡